Associate Professor of Medicine, Massachusetts General Hospital
Oncology
Dr. Elizabeth B. Lamont, MD
|
|
Give Review
Doctor Elizabeth B. Lamont, MD practices Oncology. She went to Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth has a rank of 37 in research and a 29 in primary care She over the years received 7 awards: "Certificate of Excellence In Tutoring, Among the Highest Rated Tutors by Harvard Medical Students", "Merit Award, Among Highest Ranked Fellow Abstracts", "Janet M. Glasgow Memorial Citation, First Woman in Graduating Class (2nd Overall)", "Upjohn Award, Excellence in Internal Medicine", "Alpha Omega Alpha, National Honor Society", "Hartford Foundation Student Scholar, Funding for Summer Research in Aging" and "Bishop Kelleher Award, Best Poem". Elizabeth Lamont is a published physician. She has 52 papers published. The most current publication "An occult cause of persistent nausea and vomiting." Elizabeth Lamont is registered with Medicare.
Publications
- Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients.
- Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon Cancer.
- Generalizability of trial results to elderly Medicare patients with advanced solid Tumors (Alliance 70802).
- Elderly breast and colorectal Cancer patients' clinical course: patient and contextual influences.
- Genotyping Lung Cancer Is an Investment in the Future.
- Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).
- Rural residence and Cancer outcomes in the United States: issues and challenges.
- Predictors of newly diagnosed Cancer patients' understanding of the goals of their care at initiation of chemotherapy.
- Tumor boards and the quality of Cancer care.
- Do Socially Deprived Urban Areas Have Lesser Supplies of Cancer Care Services?
- Area-Level Variations in Cancer Care and Outcomes.
- Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens.
- Understanding Variation in Primary Prostate Cancer Treatment Within the Veterans Health Administration.
- Reasons for underuse of recommended therapies for colorectal and lung Cancer in the Veterans Health Administration.
- Location of Cancer Surgery for Older Veterans with Cancer.
- Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung Cancer.
- Quality of care for older patients with Cancer in the veterans health administration versus the private sector: a cohort study.
- End-of-life care for older Cancer patients in the Veterans Health Administration versus the private sector.
- Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate Cancer prevent clinical consequences of a testost...
- Differences in clinical trial patient attributes and outcomes according to enrollment setting.
- Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives.
- Utility of administrative claims data for the study of brain metastases: a validation study.
- Secular changes in NSAID use and invasive colorectal Cancer incidence: an ecological study.
- Evaluation of trends in the cost of initial Cancer treatment.
- Cost of care for elderly Cancer patients in the United States.
- NSAIDs and colorectal Cancer risk: do administrative data support a chemopreventive effect?
- Patient time costs associated with Cancer care.
- Cancer and leukemia group B Cancer control and health outcomes committee: origins and accomplishments.
- Are venous thromboembolic events associated with subsequent breast and coloRectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries.
- Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung Cancer trial participants.
- A demographic and prognostic approach to defining the end of life.
- Patterns of presentation, diagnosis, and treatment in older patients with colon Cancer and comorbid dementia.
- Low risk of hip fracture among elderly breast Cancer survivors.
- Is patient travel distance associated with survival on phase II clinical trials in oncology?
- Complexities in prognostication in advanced Cancer: "to help them live their lives the way they want to".
- Favorable cardiac risk among elderly Breast carcinoma survivors.
- Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon Cancer.
- Physician factors in the timing of Cancer patient referral to hospice palliative care.
- Construct validity of medicare chemotherapy claims: the case of 5FU.
- Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
- Measuring disease-free survival and Cancer relapse using Medicare claims from CALGB breast Cancer trial participants (companion to 9344).
- Prognostic disclosure to patients with Cancer near the end of life.
- The oral fluoropyrimidines in Cancer chemotherapy.
- Extent and determinants of error in doctors'' prognoses in terminally ill patients: prospective cohort study.
- Imatinib mesylate in patients with adenoid cystic cancers of the salivary Glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
- Paradoxes in Cancer patients' advance care planning.
- Chemotherapy in the management of squamous-Cell carcinoma of the head and neck.
- Some elements of prognosis in terminal Cancer.
- Extent and determinants of error in physicians' prognoses in terminally ill patients: prospective cohort study.
- Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma.
- An occult cause of persistent nausea and vomiting.
Schools
Dartmouth College
New York University
Brigham and Women39s Hospital
University of Chicago
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Certificate of Excellence In Tutoring, Among the Highest Rated Tutors by Harvard Medical Students
- Merit Award, Among Highest Ranked Fellow Abstracts
- Janet M. Glasgow Memorial Citation, First Woman in Graduating Class (2nd Overall)
- Upjohn Award, Excellence in Internal Medicine
- Alpha Omega Alpha, National Honor Society
- Hartford Foundation Student Scholar, Funding for Summer Research in Aging
- Bishop Kelleher Award, Best Poem
Education
-
University of Chicago -
Brigham and Women's Hospital -
Geisel School of Medicine at Dartmouth
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Matthew L. Freedman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Iain J. Webb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitrios Spentzos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Yurgelun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M S. Donnelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alphonse G. Taghian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brian M. Wolpin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Thomas A. Abrams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah Schrag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison M. Schram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason S. Fisherman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Fallon, MD
This Doctor is OpenDoctor Recommended.
|